A national survey on myocarditis associated with influenza H1N1pdm2009 in the pandemic and postpandemic season in Japan

Journal of Infection and Chemotherapy

Volumn 19, Issue 3, 2013, Pages 426-431

  Ukimura, Akira ^a   Ooi, Yukimasa ^a   Kanzaki, Yumiko ^a   Inomata, Takayuki ^b   Izumi, Tohru ^b  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Influenza A; Myocarditis; Pandemic

Indexed keywords

ANTIVIRUS AGENT;

2009 H1N1 INFLUENZA; ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; AUTOPSY; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HEART ARRHYTHMIA; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; INTRAAORTIC BALLOON PUMP; JAPAN; MALE; MORBIDITY; MORTALITY; PANDEMIC; PNEUMONIA; QUESTIONNAIRE; SEASONAL VARIATION; VIRUS MYOCARDITIS;

EID: 84879243594     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0499-z     Document Type: Article

References (21)

1. JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version. Circ J. 2011;75:734-43.
2. Mamas MA, Fraser D, Neyses L. Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol. 2008;130:304-9.
3. Sekiguchi M, Hiroe M, Hiramitsu N. Natural history of acute viral or idiopathic myocarditis: a clinical and endomyocardial biopsy follow-up. In: Schultheiss HP, editor. New concepts of viral heart disease. Berlin: Springer; 1988. p. 33-50.
4. Bowles EN, Ni J, Kearney LD, Pauschinger M, Schultheiss HP, McCarthy R, et al. Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003;42:466-72.
5. Koide H, Kitaura Y, Deguchi H, Ukimura A, Kawamura K, Hirai K. Genomic detection of enteroviruses in the myocardium: studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy. Jpn Circ J. 1992;56:1081-93.
6. Kotaka M, Kitaura Y, Deguchi H, Kawamura K. Experimental influenza A virus myocarditis in mice. Light and electron microscopic, virologic, and hemodynamic study. Am J Pathol. 1990;136:409-19.
7. Aoyama N, Izumi T, Hiramori K, Isobe M, Kawana M, Hiroe M, et al. National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). Circ J. 2002;66:133-44.
8. Centers for Disease Control and Prevention (CDC). Patients hospitalized with 2009 pandemic influenza A (H1N1) - New York City, May 2009. MMWR Morb Mortal Wkly Rep 2010;58:1436-40.
9. Kerkhove MDV, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, et al. on behalf of the WHO Working Group for Risk Factors for Severe H1N1pdm Infection. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 2011;7:1-12.
10. The Ministry of Health, Labor, Tokyo, Japan. A national survey of influenza patients in the last winter in Japan (in Japanese). http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou04/pdf/110210-03.pdf. April 1, 2011.
11. Sugaya N. Widespread use of neuraminidase inhibitors in Japan. J Infect Chemother. 2011;17:595-601.
12. Ikematsu H, Kawai N, Kashiwagi S. In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan. J Infect Chemother 2012 (published online Feb. 28).
13. Ukimura A, Izumi T, Matsumori A, and Clinical Research Committee on Myocarditis Associated with the 2009 Influenza A (H1N1) Pandemic in Japan organized by the Japanese Circulation Society. A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan. Circ J 2010;74:2193-2199.
14. Arets HT. Myocarditis: the Dallas criteria. Hum Pathol. 1987;18:619-24.
15. Takeuchi I, Imaki R, Inomata T, Soma K, Izumi T. MRI is useful for diagnosis of H1N1 fulminant myocarditis. Circ J. 2010;74:2758-9.
16. Bratincsák A, El-Said HG, Bradley JS, Shayan K, Grossfeld PD, Cannavino CR. Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children. J Am Coll Cardiol. 2010;55:928-9.
17. Weiss TW, Knut H, Stensaeth KH, Eritsland J. Myocarditis in a juvenile patient with influenza A virus infection. Eur Heart J. 2010;31:277.
18. Pan HY, Yamada H, Chida J, Wang S, Yano M, Yao M, et al. Up-regulation of ectopic trypsins in the myocardium by influenza A virus infection triggers acute myocarditis. Cardiovasc Res. 2011;89:595-603.
19. Wang S, Le TQ, Kurihara N, Chida J, Cisse Y, Yano M, Kido H. Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. J Infect Dis. 2010;202:991-1001.
20. Wang S, Le Quang T, Chida J, Cisse Y, Yano M, Kido H. Mechanisms of matrix metalloproteinase-9 upregulation and tissue destruction in various organs in influenza A virus infection. J Med Invest. 2010;57:26-34.
21. Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell. 2011;146:980-91.